HUSCAP logo Hokkaido Univ. logo

Hokkaido University Collection of Scholarly and Academic Papers >

Sort by: In order: Results/Page Authors/Record:
Export metadata:
Showing results 1 to 4 of 4
TypeAuthor(s)TitleOther TitlesCitationCitation(alt)Issue Date
articleAra, Takahide; Endo, Tomoyuki; Goto, Hideki; Kasahara, Kohei; Hasegawa, Yuta; Yokoyama, Shota; Shiratori, Souichi; Nakagawa, Masao; Kuwahara, Ken; Takakuwa, Emi; Hashino, Satoshi; Teshima, TakanoriAntiretroviral therapy achieved metabolic complete remission of hepatic AIDS related Epstein-Barr virus-associated smooth muscle tumor-Antiviral Therapy-1-Oct-2022
articleGoto, Hideki; Makita, Shinichi; Kato, Koji; Tokushige, Kota; Fujita, Taizo; Akashi, Koichi; Izutsu, Koji; Teshima, TakanoriEfficacy and safety of tisagenlecleucel in Japanese adult patients with relapsed/refractory diffuse large B-cell lymphoma-International journal of clinical oncology-Sep-2020
article (author version)Shiratori, Souichi; Ohigashi, Hiroyuki; Ara, Takahide; Yasumoto, Atsushi; Goto, Hideki; Nakagawa, Masao; Sugita, Junichi; Onozawa, Masahiro; Kahata, Kaoru; Endo, Tomoyuki; Hashimoto, Daigo; Teshima, TakanoriHigh lymphocyte counts before antithymocyte globulin administration predict acute graft-versus-host disease-Annals of hematology-May-2021
articleGoto, Hideki; Izutsu, Koji; Ennishi, Daisuke; Mishima, Yuko; Makita, Shinichi; Kato, Koji; Hanaya, Miyoko; Hirano, Satoshi; Narushima, Kazuya; Teshima, Takanori; Nagai, Hirokazu; Ishizawa, KenichiZandelisib (ME-401) in Japanese patients with relapsed or refractory indolent non-Hodgkin's lymphoma : an open-label, multicenter, dose-escalation phase 1 study-International journal of hematology-1-Dec-2022
Showing results 1 to 4 of 4

 

Hokkaido University